The Higher Cost of Biofuels
Submitted by Judith Siers-Poisson on
A new study found that there is a higher health cost associated with corn-based biofuels than with traditional energy forms.
No
Main Source:
Topics:
Science
Support for Whistleblowers
Submitted by Judith Siers-Poisson on
The U.S. House of Representatives voted to strengthen protections for whistleblowers, especially those that work for the Transportation Security Administration (TSA) and in other areas of national security.
No
Main Source:
Topics:
This Is Your University, on Drugs
Submitted by Diane Farsetta on
In 2002, an independent study on hormone replacement therapy was halted, because the drugs were strongly linked to an "increased risk for breast cancer, heart disease, stroke and blood clots" in women. The same year, the University of Wisconsin-Madison began offering an online course, "funded entirely by a $12 million grant from Wyeth Pharmaceuticals," that "promoted hormone therapy, touted its benefits and downplayed its risks." Wyeth makes two hormone therapy drugs, Prempro and Premarin.
No
Topics:
How Big Tobacco Deals with Adverse Research -- and Researchers
Submitted by Anne Landman on
A case study in the January issue of the American Journal of Public Health shows the extent to which the tobacco industry works to derail research -- and researchers -- that could adversely affect it.
No
Topics:
How Wyeth Bought Science that Sells
Submitted by Diane Farsetta on
According to internal documents, the pharmaceutical company Wyeth "paid ghostwriters to produce medical journal articles favorable to its female hormone replacement therapy Prempro." As early as 1997, Wyeth paid the "medical writing firm" DesignWrite to publish favorable journal articles about Prempro under academics' names.
No
Main Source:
Topics:
Pharma See, Pharma Sue
Submitted by Sheldon Rampton on
The Canadian Association of University Teachers has strongly condemned a new lawsuit by the Apotex pharmaceutical company against Dr. Nancy Olivieri. As a liver specialist at the University of Toronto, Olivieri first came under attack from Apotex in 1996 when she notified her patients that she had detected toxic side effects while conducting an Apotex-sponsored study of the company's drug, deferiphone.
No
Topics:
Drugmakers' Dollars, Doctors' Disclosure Disorders
Submitted by Sheldon Rampton on
Doctors Frederick Goodwin and Joseph Biederman are counterattacking in an effort to defend their reputations following disclosures that they took millions of
No
Main Source:
Topics:
Participatory Project: What's Happening at the Climate Change Negotiations?
Submitted by Bob Burton on
As scientific warnings about the potential risks of climate change intensify, governments realize they need to at least be seen as responsive to global warming concerns. But, behind the scenes, many of the world's richest countries are dragging their feet.
Yes
Main Source:
No Science for You!
Submitted by Sheldon Rampton on
CNN has announced that it will cut its entire science, technology, and environment news staff, a move that Christy George of the Society of Environmental Journalists called "disheartening." Other networks have also been slashing science and environmental jobs, including NBC Universal's The Weather
No
Main Source:
Topics:
Pure Science vs. Biopure
Submitted by Sheldon Rampton on
Biopure, a company that makes blood substitutes, is suing scientist Charles Natanson for defamation after he published a critical review in the Journal of the American Medical Association. Nature magazine has condemned the lawsuit.
No
Main Source:
Pages
